Glaucoma News

Last Chance: Glaucoma Screening, Job Fair and Lien Sale - Patch.com



Last Chance: Glaucoma Screening, Job Fair and Lien Sale 
Patch.com
Attend career workshops at the Central Queens Y, get a free glaucoma screening and prevent the sale of a lien on your property. By Nathan Duke Time always seems to be running out, doesn't it? There's no need to worry. Just drop by Douglaston-Little ...

and more » 


700 thousand people living with glaucoma in Ghana- GAG - GhanaWeb



700 thousand people living with glaucoma in Ghana- GAG 
GhanaWeb
Statistics from the Glaucoma Association of Ghana, GAG, indicate that about seven hundred thousand people are living with glaucoma in Ghana. Out of this, about 60 thousand people have already gone blind due to glaucoma. This has been attributed to the ...

and more » 


Windows to the soul can help reveal other disorders - Sydney Morning Herald



Sydney Morning Herald
 
Windows to the soul can help reveal other disorders 
Sydney Morning Herald
Dr Sai Gandham, associate professor of ophthalmology at Albany Medical Centre in New York, says regular eye checks can help diagnose degenerative eye conditions such as glaucoma and cataracts and even if you believe your eyes are fine, it's still worth ...

and more » 


Two Glaucoma Implants Equally Good at 3 Years - Medscape



Two Glaucoma Implants Equally Good at 3 Years 
Medscape
May 11, 2012 (Fort Lauderdale, Florida) ? The Ahmed glaucoma valve and the Baerveldt glaucoma implant, the 2 most commonly used glaucoma drainage implants in the United States, are equally successful in the treatment of refractory glaucoma, ...

 


Last Chance: Free Glaucoma Screening - Patch.com



Last Chance: Free Glaucoma Screening 
Patch.com
Bob Turner will be holding a no-cost glaucoma screening on Monday, May 21 at the Walgreens parking lot, located at 80-11 Eliot Avenue in Middle Village. The screenings will take place from 10a.m. to 2p.m. No appointment is necessary.

and more » 


OphthaliX Reports First Quarter 2012 Financial Results - Sacramento Bee



OphthaliX Reports First Quarter 2012 Financial Results 
Sacramento Bee
Our drug, CF101 (known generically as IB-MECA), is being developed to treat three ophthalmic indications: dry eye syndrome; glaucoma and uveitis. We are currently: (i) conducting a Phase III trial with respect to the development of CF101 for dry eye ...

 


OphthaliX Reports First Quarter 2012 Financial Results - MarketWatch (press release)



OphthaliX Reports First Quarter 2012 Financial Results 
MarketWatch (press release)
Our drug, CF101 (known generically as IB-MECA), is being developed to treat three ophthalmic indications: dry eye syndrome; glaucoma and uveitis. We are currently: (i) conducting a Phase III trial with respect to the development of CF101 for dry eye ...

and more » 


Medicinal claims all smoke - Worcester Telegram



Medicinal claims all smoke 
Worcester Telegram
Advocates of the legislation claim that medical marijuana helps seriously ill people with cancer or AIDS or glaucoma. They paint a picture of elderly ill people who need it for pain relief. However, according to the San Diego County district attorney, ...
EDITORIAL: Pot bill bypasses drug safeguards Torrington Register Citizen

all 6 news articles » 


Fairfax County wellness calendar, May 17-24 - Washington Post



Fairfax County wellness calendar, May 17-24 
Washington Post
Glaucoma and visual acuity screening Sponsored by the Prevention of Blindness Society. Saturday, 11 am-3 pm George Mason Regional Library, 7001 Little River Tpk. Annandale. 703-256-3800. Free. Spousal bereavement support For people 59 and younger who ...

and more » 


Treating Glaucoma Using Ultrasound Generated by the EYEOP1 Device - Eye Doc News



Treating Glaucoma Using Ultrasound Generated by the EYEOP1 Device 
Eye Doc News
The EyeOP1 is a new medical device developed by EyeTechCare that uses therapeutic ultrasound to enable non-invasive treatment of refractory glaucoma. The treatment can be administered on an outpatient basis and is performed under local anaesthaesia.